The arrangement includes global product mastering, and simplified access to IQVIA’s resources for data-driven decisions.

IQVIA and its Data-as-a-Service (DaaS+) technology have been chosen by Boehringer Ingelheim in a new, strategic long-term ...

IQVIA (NYSE:IQV) shares slid Thursday. The company, priding itself on being “a leading global provider of clinical research ...

RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--IQVIA (NYSE:IQV) today announced the launch of One Home for Sites™, a new technology platform that acts as a single sign-on and a single dashboard for ...

In its upcoming report, IQVIA Holdings (IQV) is predicted by Wall Street analysts to post quarterly earnings of $3.40 per share, reflecting an increase of 9% compared to the same period last year.

IQVIA Holdings Inc. IQV yesterday unveiled a clinical trial technology platform, One Home for Sites. The platform streamlines the process of management of trials by acting as a single sign-on and a ...

On Monday, BTIG analyst David Larsen adjusted the firm's stance on IQVIA Holdings (NYSE:IQV), moving from a Buy rating to Neutral. The $36.5 billion market cap company, currently trading near its ...

Andrew Kessel was a breaking news writer for Investopedia until October 2025. He previously covered markets for Proactive Investors, with a focus on small-cap stocks in fintech, healthcare, mining, ...

IQVIA is trading at 18.2x, which is a discount compared to the industry average of 35.2x. IQV has better operating margins, operational efficiency, strong cash flows, and moderate leverage. The life ...

Bold initiative to boost the capacity of research sites enters Beta testing and piloting RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)-- IQVIA (NYSE:IQV) today announced the launch of One Home for ...